U.S. Pharma Stock News

In late February 2026, Sysco Corporation’s Chief Financial Officer Kenny Cheung resigned to join a Fortune 10 company outside foodservice, with longtime internal finance leader Brandon Sewell appointed interim CFO from March 6 while Cheung stays on as an advisor until mid-April to support continuity. By reaffirming its fiscal 2026 earnings guidance alongside the CFO transition, Sysco signaled management’s confidence in its existing financial plans and execution framework despite the...

MillerKnoll stock snapshot MillerKnoll (MLKN) is back on investor radars after recent share price moves, with the stock now around $18.96 and mixed returns across the past week, month, and past 3 months. See our latest analysis for MillerKnoll. Recent moves in MillerKnoll’s share price tell a mixed story, with a 30 day share price return of a 16.73% decline, contrasting with a 90 day share price return of a 13.81% gain and a 1 year total shareholder return of 3.23%. This suggests momentum has...

PEDEVCO (NYSEAM:PED) has expanded its board of directors and appointed Edward Geiser as a new director. Geiser will serve as Chairperson of the Nominating and Corporate Governance Committee. The company has also approved a 1 for 20 stock split, with implementation expected in the near term. PEDEVCO operates in the energy sector, where capital allocation, drilling decisions, and reservoir management are closely tied to governance quality. Adding an industry veteran like Edward Geiser to lead...

Coda Octopus Group recently reached a new 52-week high, reflecting past improvements in operational efficiency and a stronger position in its underwater technologies markets. This milestone, coupled with an increase in operating profit, highlights how the company’s business model and cost discipline may be reinforcing its industry standing. Next, we’ll explore how the improved operating profit profile could influence Coda Octopus Group’s existing investment narrative and future...

How Rubrik’s FY 2026 Numbers Frame the Story Rubrik (RBRK) just closed out FY 2026 with fourth quarter revenue of US$377.7 million and a basic EPS loss of US$0.43, alongside net income excluding extra items of a US$87.0 million loss. This puts a clear spotlight on how much of that top line is flowing through to the bottom line. The company reported revenue of US$258.1 million in Q4 FY 2025 and US$377.7 million in Q4 FY 2026, while the quarterly basic EPS loss moved from US$0.61 to US$0.43...

Unum Group (NYSE:UNM) has approved material amendments to its corporate bylaws, reshaping rules for shareholder meetings, proposals, director nominations, and indemnification. The company has also seen recent insider selling activity by a senior executive, alongside a pattern of insider sales over the past year. These governance changes and insider transactions arrive together, raising questions for investors about internal priorities and board level decision making. Unum Group, a provider...

In recent months, Grand Canyon Education has reported weaker student growth and stagnant profitability, raising concerns among investors about the resilience of its education services model. An interesting detail is that analysts now expect free cash flow margins to remain flat, signaling limited room for near-term financial improvement despite prior optimism. Next, we’ll examine how this softer student growth trend could alter Grand Canyon Education’s previously supportive investment...

EHang Holdings (NasdaqGM:EH) just posted its FY 2025 third quarter numbers, reporting revenue of C¥92.5 million and a basic EPS loss of C¥1.11, with trailing twelve month revenue at C¥430.0 million and a basic EPS loss of C¥3.98. The company has seen quarterly revenue move between C¥26.1 million and C¥164.3 million over the past six reported periods, while basic EPS losses have ranged from C¥0.66 to C¥1.12 per share. This sets up a story where growth expectations are balanced against still...

If you are wondering whether Griffon is starting to look attractively priced after its recent swings, or if the share price already reflects the story, this valuation review is designed to help you frame that question clearly. The stock closed at US$70.82, with a 7 day return of an 8.5% decline, a 30 day return of a 24.6% decline, a year to date return of a 5.6% decline, but a 1 year return of 2.9% and a 3 year return that is very large compared to the starting point. Recent price moves sit...

Quaker Chemical (NYSE:KWR) has involuntarily terminated Senior Vice President and Chief Global Operations Officer Jeffrey Fleck. The departure affects a key executive role responsible for global operations oversight. This change represents a material event for the company’s leadership and operational continuity. Jeffrey Fleck’s exit comes at a time when Quaker Chemical’s share price stands at $118.45 and recent returns have been weak, with the stock down 8.6% over the past week and 33.4%...

If you are wondering whether SIGA Technologies is attractively priced right now, this article will walk through what the current share price might be implying about its value. The stock closed at US$5.26 most recently, with returns showing a 9.3% decline over 7 days, a 20.8% decline over 30 days, a 16.1% decline year to date, but a 4.1% gain over 1 year and a 23.6% gain over 3 years that contrasts with a more modest 5.3% gain over 5 years. Recent price moves are sitting against a broader...

Plexus recently reported a strong quarter with revenues of US$1.07 billion, up 9.6% year on year and in line with analyst expectations, while also exceeding forecasts for earnings per share and issuing higher-than-expected revenue guidance for the next quarter. Management highlighted especially strong momentum in Healthcare/Life Sciences and Aerospace/Defense, underscoring how its investments in talent, technology, and advanced capabilities are reinforcing these higher-complexity,...

Director Carol Schneeberger has recently sold shares in Peoples Bancorp. The transactions involved insider stock sales with no corresponding insider purchases reported in the same period. The trades come with Peoples Bancorp shares last closing at $31.6 on the NasdaqGS under ticker NasdaqGS:PEBO. For investors tracking insider activity at Peoples Bancorp, the recent share sale by Director Carol Schneeberger adds a fresh data point to the story around NasdaqGS:PEBO. The stock last closed at...

KORU Medical Systems (KRMD) has just posted its FY 2025 third quarter numbers, with revenue of about US$10.4 million and a basic EPS loss of roughly US$0.02, underscoring that the company is still in the red. The company has seen revenue move from about US$8.2 million in Q3 FY 2024 to US$10.4 million in Q3 FY 2025, while quarterly basic EPS has ranged between a loss of roughly US$0.03 and US$0.02 over that period. As a result, investors are likely to focus on how quickly margins can tighten...

If you are wondering whether BrightView Holdings is attractively priced or just a value trap, you are in the right place to unpack what the current share price really reflects. The stock last closed at US$11.81, with returns of 7.2% decline over 7 days, 15.5% decline over 30 days, a 6.3% decline year to date, a 10.9% decline over 1 year, a 102.6% gain over 3 years and a 30.4% decline over 5 years. Taken together, this gives you a mixed picture of how sentiment has shifted over different...

If you are wondering whether Karman Holdings at around US$99.98 is still fairly priced or starting to look stretched, you are not alone. The stock has seen a 25.7% return over the past 30 days, 30.1% year to date, and 201.5% over the last year, with a small 0.6% decline in the most recent 7 days. Recent coverage has focused on Karman Holdings as an evergreen story for investors who want ongoing insight into the stock, with attention on how its share price has moved over different time frames...

Why Sonida Senior Living Is On Investors’ Radar Sonida Senior Living (SNDA) has drawn attention after recent share price swings, with a 1 day return of 4.34% contrasting with a 4.28% decline over the past week. This has prompted closer portfolio reviews. See our latest analysis for Sonida Senior Living. That sharp 1 day share price return of 4.34% comes after a softer 7 day share price return of 4.28%. Sonida Senior Living still has a 90 day share price return of 13.06% and a 1 year total...

If you are wondering whether ACADIA Pharmaceuticals at around US$20.61 is offering good value or just fresh risk, you are in the right place for a closer look at what that price might represent. The share price has seen a 7% decline over the last week, an 8.3% decline over the last month, but a 17.8% return over the last year. This can leave investors questioning whether recent weakness is a setback or a reset after earlier gains. Recent attention on ACADIA has centered on its product...

Eastman Chemical (NYSE:EMN) has rolled out a new 2026 self help plan focused on deeper cost reductions and operational efficiency. The plan also targets expanded capital returns, signaling an intention to keep shareholder payouts in focus alongside internal improvements. Management is positioning the initiative as a material shift in how the company runs its business and allocates cash over the next few years. Eastman Chemical is launching this plan at a time when the stock has faced mixed...

Via Transportation (NYSE:VIA) reports material improvements in city transit performance in the City of Mobile, including better reliability and staffing outcomes without additional budget. The company expands its work with Transport for West Midlands in the UK, adding Citymapper integration to support future regional transit planning. These developments highlight Via’s growing role as a partner for large scale public transit transformation across multiple geographies. Via Transportation,...

MicroVision, Inc. has reported its full-year 2025 results, with sales of US$1.21 million compared to US$4.70 million in 2024 and a net loss of US$94.98 million versus US$96.92 million, while basic loss per share from continuing operations narrowed to US$0.35 from US$0.46. The combination of falling revenue and a slightly smaller loss highlights the company’s challenge of scaling its business while still tightly managing costs. With sales declining year over year but net loss narrowing, we’ll...

Zacks Equity Research recently highlighted Spire Inc.’s long-term infrastructure and innovation plans, including an expected US$11.20 billion in capital investments over the next decade, alongside its current 3.59% dividend yield and analyst estimates for long-term earnings growth. The analysis underscores how these planned investments and anticipated earnings expansion could influence Spire’s role in a gas utility sector balancing aging infrastructure, renewable competition, and the...

McEwen (MUX) closed out FY 2025 with Q4 revenue of US$64.6 million and basic EPS of US$0.70, alongside net income of US$38.1 million, putting a clear marker on its latest financial run rate. Over the year, quarterly revenue ranged from US$35.7 million in Q1 to US$64.6 million in Q4, while basic EPS moved between a loss of US$0.12 and a gain of US$0.70, giving investors a wide view of how profitability has tracked against the top line. Overall, the results point to firmer margins in the latest...

Clarivate (NYSE:CLVT) has integrated its regulatory intelligence with Anthropic's Claude AI assistant. The collaboration embeds Clarivate's regulatory data directly into biopharma, biotech, and medtech AI workflows. The move is aimed at supporting regulatory affairs teams by keeping trusted data closer to day to day decision making. Clarivate focuses on data, analytics, and workflow tools for research driven industries, and life sciences is a core part of that mix. By plugging its...